CAS RN: 445302-27-2
1H-Imidazole-4-carboxylic acid, 1-(4-bromophenyl)-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260103
100mg / 250mg / 1g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 445302-27-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>95%
0
Out of Stock
Shanghai
Inquiry
445302-27-2 / 1-(4-bromophenyl)imidazole-4-carboxylic acid
Standard CAS: 445302-27-2
Multi CAS: No
Basic Information
copy
CAS
445302-27-2 copy
Multi CAS
No copy
Molecular Formula
BC10H7O2Rn2 copy
Molecular Weight
267.080000 copy
Exact Mass
265.969090 copy
InChI
InChI=1S/C10H7BrN2O2/c11-7-1-3-8(4-2-7)13-5-9(10(14)15)12-6-13/h1-6H,(H,14,15) copy
InChIKey
BOXLOBBFTWDLPD-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
11 copy
Rotatable bonds
2 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
58.22 copy
TPSA
55.12 copy
LogP / Solubility
WLOGP
2.33 copy
MLOGP
2.06 copy
XLogP3
2.2 copy
Consensus LogP
2.2 copy
Log S (ESOL)
-3.38 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.43 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.57 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.69 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy